Beatrix Lutiger

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

Philip A. Poole‐Wilson, Karl Swedberg, John G.F. Cleland et al. · The Lancet · 2003 · 1.9K citations · Full text

Medicine, Cardiology, Pharmacology +13

Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial

Marco Metra, Christian Torp‐Pedersen, Karl Swedberg et al. · European Heart Journal · 2005 · 179 citations · Full text

Medicine, Cardiology, Pharmacology +17

The Benefits of Early Combination Treatment of Carvedilol and an ACE-Inhibitor in Mild Heart Failure and Left Ventricular Systolic Dysfunction. The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure Evaluation Trial (CARMEN)

Willem J. Remme, G. Riegger, Per Hildebrandt et al. · Cardiovascular Drugs and Therapy · 2004 · 153 citations

Medicine, Cardiology, Pharmacology +14

Bevacizumab Prevents Brain Metastases Formation in Lung Adenocarcinoma

Aysegül Ilhan‐Mutlu, Matthias Osswald, Yunxiang Liao et al. · Molecular Cancer Therapeutics · 2016 · 122 citations · Full text

Medicine, Oncology, Pharmacology +17

Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure—COMET

Christian Torp‐Pedersen, Philip A. Poole‐Wilson, Karl Swedberg et al. · American Heart Journal · 2005 · 86 citations

Medicine, Cardiology, Pharmacology +12